tirzepatide side effects last how long 20 Possible Long-Term to Be Aware Of Zepbound (Tirzepatide) Side Effects: Common

Expect that some side effects, particularly nausea, may return temporarily after the dose increase, though they are usually milder than the first time

However, that is both Wegovy 7.2mg and CagriSema (2 assets) that are competitive to Tirzepatide SURMOUNT-1 data as a placebo-adjusted weight loss of -20.1% and likely to be in commercialisation in the US in 2026 and early 2027

Meanwhile, Structure Therapeutics reported positive mid-stage results for its oral GLP-1 agonist aleniglipron in adults with obesity, with plans to initiate a Phase III program by mid-2026 following discussions with the FDA

One Molecule = A Complete Shift in How Your Body Handles Food GLP-1 is the hormone your intestines release in response to eating